LYNN NEUBURGER: Open Payments
NPI 1306879986 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 35 payments from 10 companies in 2025. Trend: 2023 $653 · 2024 $714 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $173 |
| Novo Nordisk Inc | 8 | $143 |
| Lilly USA, LLC | 4 | $84 |
| Amgen Inc. | 4 | $79 |
| Corcept Therapeutics | 3 | $72 |
| PFIZER INC. | 3 | $67 |
| Exact Sciences Corporation | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: VRAYLAR, Korlym, OTEZLA, Wegovy, Cologuard Collection Kit, Ozempic, ZEPBOUND, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
